Holen Sie sich die Stockscreener-App
1.12
5.66%
0.06
Handel nachbörslich:
1.12
Schlusskurs vom Vortag:
$1.06
Offen:
$1.06
24-Stunden-Volumen:
596.36K
Relative Volume:
0.72
Marktkapitalisierung:
$82.42M
Einnahmen:
$311.14M
Nettoeinkommen (Verlust:
$-177.97M
KGV:
-0.4422
EPS:
-2.5329
Netto-Cashflow:
$-20.82M
1W Leistung:
+1.82%
1M Leistung:
-15.15%
6M Leistung:
-61.38%
1J Leistung:
-70.83%
1-Tages-Spanne:
$1.06
$1.13
1-Wochen-Bereich:
$0.9551
$1.16
52-Wochen-Spanne:
$0.9551
$5.062
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
1.12 | 73.31M | 311.14M | -177.97M | -20.82M | -2.5329 |
VEEV
Veeva Systems Inc
|
159.09 | 24.73B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
49.53 | 7.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
46.04 | 8.71B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
81.36 | 6.59B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
22.43 | 4.12B | 1.10B | 112.09M | 283.19M | 0.6096 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-08-27 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
Health Catalyst (HCAT) price target decreased by 45.97% to 2.14 - MSN
Global Patient Engagement Solutions Market to Grow by - GlobeNewswire
Global Patient Engagement Solutions Market to Grow by $21.76 Billion Through 2030McKesson, Veradigm, Oracle, Athenahealth, and Health Catalyst Dominate - Yahoo Finance Singapore
Health Catalyst, Commerce, DocuSign, Unity, and Workiva Shares Plummet, What You Need To Know - Yahoo Finance
Health Catalyst, Inc. (HCAT) cut to equal weight at Wells Fargo on prolonged revenue, margin pressure - MSN
Doximity, Guidewire Software, Intuit, PagerDuty, and Health Catalyst Shares Plummet, What You Need To Know - Yahoo Finance
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Sleep Number, Viking, Hain Celestial, Health Catalyst, and Academy Sports Shares Plummet, What You Need To Know - Yahoo Finance
Growth Report: Is Health Catalyst Inc a top pick in the sectorBreakout Watch & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Health Catalyst CEO Retirement Accelerated With Advisory Role - TipRanks
Health Catalyst enters transition agreement with former CEO Daniel Burton By Investing.com - Investing.com India
Health Catalyst enters transition agreement with former CEO Daniel Burton - Investing.com
Health Catalyst names Daniel Burton strategic advisor after accelerating retirement as CEO - TradingView — Track All Markets
Daniel Burton’s transition deal at Health Catalyst (HCAT) details advisory role - Stock Titan
List of 12 Acquisitions by Health Catalyst (Apr 2026) - Tracxn
Down 20.4% in 4 Weeks, Here's Why Health Catalyst (HCAT) Looks Ripe for a Turnaround - Eastern Progress
Here's Why Health Catalyst (HCAT) Is a Great 'Buy the Bottom' Stock Now - Eastern Progress
Evercore ISI Reaffirms Their Hold Rating on Health Catalyst (HCAT) - The Globe and Mail
Dynatrace, Five9, Health Catalyst, RingCentral, and ZoomInfo Shares Skyrocket, What You Need To Know - Yahoo Finance
Aug Drivers: How liquid is Health Catalyst Inc stock2026 Catalysts & Accurate Entry/Exit Alerts - baoquankhu1.vn
Vanguard disaggregates holdings; subsidiaries now report separately (HCAT) - stocktitan.net
Health Catalyst downgraded at Wells Fargo after Q4 results - MSN
How The Health Catalyst (HCAT) Investment Story Is Shifting As Analysts Reset Expectations - Yahoo Finance
Health Catalyst, Asure Software, GitLab, Zeta Global, and SoundHound AI Shares Plummet, What You Need To Know - Yahoo Finance
Health Catalyst (HCAT) Q4 2025 Earnings Transcript - AOL.com
If You Invested $1,000 in Health Catalyst (HCAT) - Stock Titan
Health Catalyst, Inc. (HCAT) Cut to Equal Weight at Wells Fargo on Prolonged Revenue, Margin Pressure - Yahoo Finance
Health Catalyst, Inc. (NASDAQ:HCAT) Q4 2025 Earnings Call Transcript - Insider Monkey
Health Catalyst (HCAT) Stock Trades Down, Here Is Why - Yahoo Finance
Health Catalyst, IncCommon stock (NQ: HCAT - The Chronicle-Journal
Wells Fargo Adjusts Outlook for Health Catalyst (HCAT) - gurufocus.com
Health Catalyst stock downgraded at Wells Fargo (HCAT:NASDAQ) - Seeking Alpha
Total debt per share of Health Catalyst, Inc. – FWB:2YP - TradingView
Health Catalyst down as Piper Sandler adds to downgrades on Q2 results - MSN
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
1.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):